Canada markets open in 55 minutes

Walvax Biotechnology Co., Ltd. (300142.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
12.24-0.23 (-1.84%)
At close: 03:04PM CST
Full screen
Previous Close12.47
Open12.78
Bid12.22 x 0
Ask12.23 x 0
Day's Range12.11 - 12.36
52 Week Range12.11 - 28.45
Volume16,043,933
Avg. Volume16,098,050
Market Cap19.649B
Beta (5Y Monthly)0.66
PE Ratio (TTM)76.50
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.01 (0.08%)
Ex-Dividend DateMay 30, 2024
1y Target EstN/A
  • Reuters

    FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet

    China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.